Agenda

5 min           Welcome and Introductions

25 min         Exploring the Evolving Role of Actionable Mutations

                    in the Management and Treatment of NSCLC

25 min         Using Biomarkers to Identify Treatment Targets in NSCLC:

                    Case-based Discussions

5 min           Conversation with the Expert/Audience Q&A